Literature DB >> 28691504

Takotsubo Cardiomyopathy: Another Form of Cardiorenal Syndrome.

Verena Bill1,2, Ibrahim El-Battrawy1,2, Ursula Hoffmann1,2, Darius Haghi1,2, Jürgen Kuschyk1,2, Martin Borggrefe1,2, Ibrahim Akin1,2.   

Abstract

Takotsubo cardiomyopathy (TC) is a life-threatening syndrome with ambiguous pathophysiology. The interdependency between heart failure and kidney failure (KF) is well established, but the influence of KF on TC outcome is not known. This single-center cohort from January 2003 to September 2015 consisted of 114 consecutive patients with TC. They were divided into 2 groups according to the presence (n = 32, 29.6%) or absence (n = 76, 70.3%) of KF. The end point of this retrospective study was a composite of in-hospital events, all-cause mortality, rehospitalization due to heart failure, stroke, and recurrence of TC (mean follow-up: 5 years). Although there were no differences in baseline characteristics between patients with/without KF, we found a significantly higher mortality rate in those with KF, 1 (7.9% vs 21.8%, P < .05), 2 (11.8% vs 31.5%, P < .05), and 5 years (22.3% vs 43.7%, P < .05) after the index event. There were no differences in life-threatening arrhythmias, cardiogenic shock, cardiopulmonary resuscitation, and thromboembolic events in both groups at the index event. Patients with TC and KF have a much worse long-term prognosis. This is clinically relevant, but the mechanisms responsible remain to be determined.

Entities:  

Keywords:  Takotsubo cardiomyopathy; Takotsubo predisposing factors; acute left ventricular dysfunction; kidney failure; mortality

Mesh:

Year:  2017        PMID: 28691504     DOI: 10.1177/0003319717718978

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  1 in total

1.  Kidney Failure among Patients with Takotsubo Syndrome or Myocardial Infarction: A Retrospective Analysis.

Authors:  Verena Bill; Ibrahim El-Battrawy; Marvin Kummer; Andreas Mügge; Assem Aweimer; Michael Behnes; Ibrahim Akin
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.